Ignite Creation Date:
2025-12-25 @ 1:26 AM
Ignite Modification Date:
2025-12-27 @ 11:41 PM
Study NCT ID:
NCT00412893
Status:
COMPLETED
Last Update Posted:
2024-12-10
First Post:
2006-12-18
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Isavuconazole (BAL8557) for Primary Treatment of Invasive Aspergillosis
Sponsor:
Astellas Pharma Inc
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-03-07
Start Date Type:
ACTUAL
Primary Completion Date:
2013-03-28
Primary Completion Date Type:
ACTUAL
Completion Date:
2013-03-28
Completion Date Type:
ACTUAL
First Submit Date:
2006-12-18
First Submit QC Date:
None
Study First Post Date:
2006-12-19
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2015-03-19
Results First Submit QC Date:
None
Results First Post Date:
2015-03-31
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2014-04-09
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2024-11-15
Last Update Post Date:
2024-12-10
Last Update Post Date Type:
ACTUAL